10.7？-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

Glorious
2020-02-10

10.7？

小摩：维持阿里健康(00241)“增持”评级目标价10.7港元

智通财经APP获悉，小摩发布报告称，阿里健康(00241)日前公布向母公司阿里巴巴(09988)收购天猫药品销售平台，目标业务于截至去年3月底止年度产生总交易金额约95.75亿元人民币，交易总对价80

小摩：维持阿里健康(00241)“增持”评级目标价10.7港元

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":914689903,"tweetId":"914689903","gmtCreate":1581309233902,"gmtModify":1705425803502,"author":{"id":3486434274927095,"idStr":"3486434274927095","authorId":3486434274927095,"authorIdStr":"3486434274927095","name":"Glorious","avatar":"https://static.laohu8.com/7f9c7f1d9264bb8351b6c78498c677e3","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\n10.7？</body></html>","htmlText":"<html><head></head><body>\n10.7？</body></html>","text":"10.7？","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/914689903","repostId":2010240500,"repostType":2,"repost":{"id":"2010240500","kind":"news","pubTimestamp":1581307330,"share":"https://www.laohu8.com/m/news/2010240500?lang=&edition=full","pubTime":"2020-02-10 12:02","market":"hk","language":"zh","title":"小摩：维持阿里健康(00241)“增持”评级 目标价10.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2010240500","media":"智通财经","summary":"智通财经APP获悉，小摩发布报告称，阿里健康(00241)日前公布向母公司阿里巴巴(09988)收购天猫药品销售平台，目标业务于截至去年3月底止年度产生总交易金额约95.75亿元人民币，交易总对价80","content":"<html><body><article><p>智通财经APP获悉，小摩发布报告称，<a href=\"https://laohu8.com/S/00241\">阿里健康</a>(00241)日前公布向母公司<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>(09988)收购天猫药品销售平台，目标业务于截至去年3月底止年度产生总交易金额约95.75亿元人民币，交易总对价80.75亿元，相当于估值/平台总交易额约0.76倍。</p><p>该行补充，对上述交易感正面，更称注入药物业务的时机佳，将有助阿里健康开拓内地网上处方药销售平台，更强化阿里健康作为阿里巴巴大健康旗舰平台的地位，相信短期内对阿里健康股价会有正面刺激作用。该行表示，维持其“增持”评级，目标价10.7港元。</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>小摩：维持阿里健康(00241)“增持”评级 目标价10.7港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n小摩：维持阿里健康(00241)“增持”评级 目标价10.7港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-02-10 12:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，小摩发布报告称，阿里健康(00241)日前公布向母公司阿里巴巴(09988)收购天猫药品销售平台，目标业务于截至去年3月底止年度产生总交易金额约95.75亿元人民币，交易总对价80.75亿元，相当于估值/平台总交易额约0.76倍。该行补充，对上述交易感正面，更称注入药物业务的时机佳，将有助阿里健康开拓内地网上处方药销售平台，更强化阿里健康作为阿里巴巴大健康旗舰平台的地位，相信...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/331014881ee5d50c3f903d427c33934b","relate_stocks":{"00241":"阿里健康","JPM":"摩根大通"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2010240500","content_text":"智通财经APP获悉，小摩发布报告称，阿里健康(00241)日前公布向母公司阿里巴巴(09988)收购天猫药品销售平台，目标业务于截至去年3月底止年度产生总交易金额约95.75亿元人民币，交易总对价80.75亿元，相当于估值/平台总交易额约0.76倍。该行补充，对上述交易感正面，更称注入药物业务的时机佳，将有助阿里健康开拓内地网上处方药销售平台，更强化阿里健康作为阿里巴巴大健康旗舰平台的地位，相信短期内对阿里健康股价会有正面刺激作用。该行表示，维持其“增持”评级，目标价10.7港元。","news_type":1},"isVote":1,"tweetType":1,"viewCount":171,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}